Apomorphine can increase cutaneous inhibition of motor activity in Parkinson's disease

By Clouston P.D.   Lim C.L.   Sue C.   Morris J.G.L.   Yiannikas C.  

Electroencephalography and Clinical Neurophysiology/ Electromyography and Motor Control, Vol. 101, Iss. 1, 1996-02 ,pp. : 8-15

Elsevier

Access to resources Recommend Favorite

Apomorphine can increase cutaneous inhibition of motor activity in Parkinson's disease

By Clouston P.D.   Lim C.L.   Sue C.   Morris J.G.L.   Yiannikas C.  

Electroencephalography and Clinical Neurophysiology, Vol. 101, Iss. 1, 1996-02 ,pp. : 8-15

Elsevier

Access to resources Recommend Favorite

Neuroprotective Therapy for Parkinson's Disease

By Koller W.C.  

Experimental Neurology, Vol. 144, Iss. 1, 1997-03 ,pp. : 24-28

Elsevier

Access to resources Recommend Favorite

Effect of Acute l-Dopa Pretreatment on Apomorphine-Induced Rotational Behavior in a Rat Model of Parkinson's Disease

By Mandel R.J.  

Experimental Neurology, Vol. 161, Iss. 1, 2000-01 ,pp. : 212-219

Elsevier

Access to resources Recommend Favorite

Growth hormone response in low-dose apomorphine test correlates with nigrostriatal dopamine transporter binding in patients with Parkinson’s disease

By Happe S.   Tings T.   Koch W.   Welsch J.   Helmschmied K.   Baier P. C.   Meller J.   Wuttke W.   Paulus W.   Tatsch K.   Trenkwalder C.  

Journal of Neural Transmission, Vol. 114, Iss. 5, 2007-05 ,pp. : 589-594

Springer Publishing Company

Access to resources Recommend Favorite